KA
RCPI

Klingman & Associates’s ROCK CREEK PHARMACEUTICALS INC COM STK (DE) RCPI Stock Holding History

Klingman & Associates’s Portfolio RCPI Stock Details RCPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-829
Closed – – 450
2015
Q3 		$0 Hold
829
– – ﹤0.01% 471
2015
Q2 		$1K Buy
+829
New +$1.97K ﹤0.01% 399

Other funds holding RCPI

Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
KCM
Kempner Capital Management Galveston, Texas $106M AUM 29.1% 1-Year Est. Return
WP
WealthPLAN Partners Omaha, Nebraska $523M AUM 23.92% 1-Year Est. Return
IWMPD
Integrated Wealth Management (Palm Desert) Palm Desert, California $299M AUM 12.85% 1-Year Est. Return

Klingman & Associates's RCPI Position: Q4 2015 in Review

Klingman & Associates sold out of ROCK CREEK PHARMACEUTICALS INC COM STK (DE) (RCPI) in Q4 2015, closing a stake of 829 shares.

Klingman & Associates first reported a position in RCPI in Q2 2015 and held it in 2 quarters. The position peaked at $1K in Q2 2015. 9 funds tracked by Wall St. Rank hold RCPI as of Q4 2015.

  • Klingman & Associates reported no remaining ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
  • Klingman & Associates sold 829 ROCK CREEK PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015.
  • Klingman & Associates first reported a position in ROCK CREEK PHARMACEUTICALS INC COM STK (DE) in Q2 2015 and held it in 2 quarters.
  • Klingman & Associates's ROCK CREEK PHARMACEUTICALS INC COM STK (DE) position peaked at $1K in Q2 2015.
  • 9 funds tracked by Wall St. Rank held ROCK CREEK PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Klingman & Associates's 13F filing for Q4 2015, filed 9 Feb 2016.